Stocks
Adaptive Biotechnologies (ADPT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 3.84 | 1.16 | 2.01 | 1.38 | 0.65 | 1.24 | |||
| Changes by years, y/y, % | -45% | -70% | +72% | -31% | -53% | -29.6% | |||
Adaptive Biotechnologies. Debt/EBITDA
Adaptive Biotechnologies. Debt/EBITDA, changes, %
Adaptive Biotechnologies (ADPT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | 1.93 | 1.55 | 1.39 | 0.66 | 1.26 | 1.24 | ||
| Changes by years, y/y, % | +52% | -22% | -36% | -70% | -36% | |||
| Changes by quarters, q/q, % | -1% | -20% | -10% | -53% | +92% | |||
